BioScience Health Innovations, Inc. (BHIC)
| Market Cap | 47.16M |
| Revenue (ttm) | 5.21M +86.5% |
| Net Income | -14.62K |
| EPS | -0.01 |
| Shares Out | 11.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 21,100 |
| Open | 4.470 |
| Previous Close | 4.371 |
| Day's Range | 4.070 - 4.470 |
| 52-Week Range | 0.520 - 9.980 |
| Beta | 1.33 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 5, 2026 |
About BHIC
BioScience Health Innovations, Inc. operates as a health and wellness innovation company focuses on mitochondrial health science, advanced peptide delivery, and metabolic care in the United States. It offers nutritional supplements, peptides, and bioactive compounds through its core technology Mineral Oxide Delivery System, as well as provides Oracle NetSuite, an accounting and financial reporting system. The company also provides services, including testosterone and hormonal Optimization, NAD+ and cellular health, and platform licensing and pe... [Read more]
Financial Performance
In 2025, BHIC's revenue was $5.69 million, an increase of 208.34% compared to the previous year's $1.84 million. Earnings were $642,090, an increase of 638.03%.
Financial StatementsNews
Rebelution Partners with Best 365 Labs and Growvana to Scale Science-Backed Cellular Health on Amazon and Beyond
Pioneering NAD and Mitochondrial Optimization Company Taps Rebelution E-Commerce's Infrastructure to Deliver Affordable, Ground-Zero Natural Health and Wellness to Everyone. CHICAGO, March 12, 2026 /P...